Acorda Therapeutics, Inc. (ACOR)
NASDAQ: ACOR · IEX Real-Time Price · USD
11.91
-0.48 (-3.87%)
At close: Mar 27, 2024, 4:00 PM
11.60
-0.31 (-2.60%)
After-hours: Mar 27, 2024, 4:04 PM EDT
Acorda Therapeutics Market Cap
Acorda Therapeutics has a market cap or net worth of $15.40 million as of March 28, 2024. Its market cap has increased by 2.68% in one year.
Market Cap
15.40M
Enterprise Value
167.91M
1-Year Change
2.68%
Ranking
Category
Stock Price
$11.91
Market Cap Chart
Since February 10, 2006, Acorda Therapeutics's market cap has decreased from $128.00M to $15.40M, a decrease of -87.97%. That is a compound annual growth rate of -11.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 14.80M | -1.33% |
Mar 26, 2024 | 15.00M | -1.96% |
Mar 25, 2024 | 15.30M | 2.00% |
Mar 22, 2024 | 15.00M | - |
Mar 21, 2024 | 15.00M | -3.23% |
Mar 20, 2024 | 15.50M | -6.06% |
Mar 19, 2024 | 16.50M | -1.79% |
Mar 18, 2024 | 16.80M | 9.09% |
Mar 15, 2024 | 15.40M | -4.35% |
Mar 14, 2024 | 16.10M | 4.55% |
Mar 13, 2024 | 15.40M | -1.91% |
Mar 12, 2024 | 15.70M | 5.37% |
Mar 11, 2024 | 14.90M | -6.29% |
Mar 8, 2024 | 15.90M | -6.47% |
Mar 7, 2024 | 17.00M | 3.03% |
Mar 6, 2024 | 16.50M | 2.48% |
Mar 5, 2024 | 16.10M | -0.62% |
Mar 4, 2024 | 16.20M | -7.95% |
Mar 1, 2024 | 17.60M | 4.14% |
Feb 29, 2024 | 16.90M | - |
Feb 28, 2024 | 16.90M | 1.81% |
Feb 27, 2024 | 16.60M | -7.78% |
Feb 26, 2024 | 18.00M | 11.11% |
Feb 23, 2024 | 16.20M | -3.57% |
Feb 22, 2024 | 16.80M | -4.00% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
MIRA Pharmaceuticals | 16.11M |
TFF Pharmaceuticals | 15.99M |
NEXGEL | 15.67M |
BiomX | 15.56M |
CareMax | 15.44M |
Cocrystal Pharma | 15.16M |
Evaxion Biotech | 15.06M |
Alterity Therapeutics | 14.93M |